Significant Revenue Growth
Total revenue for Q3 2024 was $78.8 million, a 26% increase from $62.7 million in Q3 2023.
Adjusted EBITDA Increase
Adjusted EBITDA for Q3 2024 was $13.5 million, up 938% from $1.3 million in Q3 2023.
Growth in Hospital Visits
Hospital division reported 41,668 visits in Q3 2024, an 11.3% increase over Q3 2023.
Operational Efficiency Improvements
Facility operating costs reduced to 72.2% of total revenue in Q3 2024 compared to 88.7% in Q3 2023.
Strong Cash Flow
Net cash from operating activities was $23.1 million for Q3 2024, up from $3 million in Q3 2023, a 67% increase.
Successful Cost Control Measures
Implemented cost-saving strategies in labor, supply chain, and contract services.